Extraperitoneal laparoscopic versus transperitoneal robot-assisted laparoscopic approaches during radical prostatectomy for low-risk or intermediate-risk prostate cancer
- PMID: 40376533
- PMCID: PMC12076224
- DOI: 10.21037/tau-2024-748
Extraperitoneal laparoscopic versus transperitoneal robot-assisted laparoscopic approaches during radical prostatectomy for low-risk or intermediate-risk prostate cancer
Abstract
Background: Extraperitoneal laparoscopic radical prostatectomy (E-LRP) and transperitoneal robotic-assisted laparoscopic radical prostatectomy (TRA-LRP) are two types of radical prostatectomy widely used at present, but the comparative study between them is limited. We aimed to compare E-LRP with TRA-LRP in the treatment of low- or intermediate-risk prostate cancer (PCa).
Methods: From June 2020 to May 2024, in our department, a total of 80 patients with low- or intermediate-risk PCa, including 45 cases who received E-LRP (E-LRP group) and another 35 cases who received TRA-LRP (TRA-LRP group), were enrolled in our research. All patients were followed up for 6-24 months. Perioperative parameters, erectile function, urinary continence, and biochemical recurrence were compared between the 2 groups.
Results: Patients in the TRA-LRP group had longer operative times (165.3 vs. 128.4 min, P<0.05), lesser blood loss (89.6 vs. 139.4 mL, P<0.05), and lower positive surgical margin (PSM) rate (17.1% vs. 37.8%, P<0.05) compared with the E-LRP group. Potent patients who received TRA-LRP showed better potency recovery than those who received E-LRP at 6 months postoperatively (P<0.05). Continence at the first month after TRA-LRP was significantly higher than that after E-LRP (P<0.05). All patients recovered continence at 12 months after operation. None of the patients had biochemical recurrence during the follow-up.
Conclusions: Compared with E-LRP, TRA-LRP can reduce the blood loss and PSM rate in low-risk or intermediate-risk PCa, and may help patients regain early continence and potency after operation. It may be superior in reducing intraoperative risk, improving oncological outcomes, and early postoperative rehabilitation.
Keywords: Extraperitoneal; laparoscopic; prostatectomy; robot; transperitoneal.
Copyright © 2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-2024-748/coif). The authors have no conflicts of interest to declare.
Similar articles
-
Comparison of Perioperative, Functional, and Oncological Outcomes of Transperitoneal and Extraperitoneal Laparoscopic Radical Prostatectomy.Minim Invasive Surg. 2023 Feb 7;2023:3263286. doi: 10.1155/2023/3263286. eCollection 2023. Minim Invasive Surg. 2023. PMID: 36798670 Free PMC article.
-
Transperitoneal versus extraperitoneal robot-assisted laparoscopic radical prostatectomy: A prospective single surgeon randomized comparative study.Int J Urol. 2015 Oct;22(10):916-21. doi: 10.1111/iju.12854. Epub 2015 Jul 26. Int J Urol. 2015. PMID: 26212891 Clinical Trial.
-
Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy.Eur Urol. 2014 Mar;65(3):610-9. doi: 10.1016/j.eururo.2012.11.049. Epub 2012 Dec 1. Eur Urol. 2014. PMID: 23245815
-
Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer: perioperative, functional, and oncological outcomes: A Systematic review and meta-analysis.Medicine (Baltimore). 2019 May;98(22):e15770. doi: 10.1097/MD.0000000000015770. Medicine (Baltimore). 2019. PMID: 31145297 Free PMC article.
-
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers.J Endourol. 2010 Dec;24(12):2003-15. doi: 10.1089/end.2010.0295. Epub 2010 Oct 13. J Endourol. 2010. PMID: 20942686 Free PMC article. Review.
References
-
- Yang Y, Luo Y, Hou GL, et al. Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up. Clin Genitourin Cancer 2016;14:e321-7. 10.1016/j.clgc.2015.11.009 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous